HUANG; Chia-Yu
Patent Applications and Registrations
Patent applications and USPTO patent grants for HUANG; Chia-Yu.The latest application filed is for "substituted heterocycles as cyclic trex1 inhibitors".
- HUANG; Chia-Yu - West Windsor NJ
- Huang; Chia-Yu - Princeton Junction NJ
- Huang; Chia-Yu - Taichung N/A TW
- Huang; Chia-Yu - Taichung City TW
- Huang; Chia-Yu - Plainsboro NJ
| Patent | Date |
|---|---|
| Substituted Heterocycles As Cyclic Trex1 Inhibitors App 20220213111 - LETOURNEAU; Jeffrey J. ; et al. | 2022-07-07 |
| Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors Grant 11,306,098 - Letourneau , et al. April 19, 2 | 2022-04-19 |
| Novel Sting Agonists App 20220048936 - DILLER; David J. ; et al. | 2022-02-17 |
| Non-systemic TGR5 agonists Grant 11,236,055 - Huang , et al. February 1, 2 | 2022-02-01 |
| Sting agonists Grant 11,161,864 - Diller , et al. November 2, 2 | 2021-11-02 |
| Sting Agonists For Treating Bladder Cancer And Solid Tumors App 20210060041 - McGUINNESS; Brian F. ; et al. | 2021-03-04 |
| Cyclic Trex1 Inhibitors App 20210015829 - LETOURNEAU; Jeffrey J. ; et al. | 2021-01-21 |
| Novel Cyclic Trex1 Inhibitors App 20200317677 - Letourneau; Jeffrey J. ; et al. | 2020-10-08 |
| Novel Non-systemic Tgr5 Agonists App 20200308122 - Huang; Chia-Yu ; et al. | 2020-10-01 |
| Non-systemic TGR5 agonists Grant 10,654,834 - Huang , et al. | 2020-05-19 |
| Novel Sting Agonists App 20200131209 - Diller; David J. ; et al. | 2020-04-30 |
| Novel Non-systemic Tgr5 Agonists App 20190330191 - Huang; Chia-Yu ; et al. | 2019-10-31 |
| Resistance adjustable rotational exerciser Grant 8,845,500 - Huang September 30, 2 | 2014-09-30 |
| Resistance Adjustable Rotational Exerciser App 20130260969 - Huang; Chia-Yu | 2013-10-03 |
| Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands Grant 8,513,232 - Bacon , et al. August 20, 2 | 2013-08-20 |
| Functionally selective alpha2C adrenoreceptor agonists Grant 8,501,747 - de lera Ruiz , et al. August 6, 2 | 2013-08-06 |
| ALPHA2C adrenoreceptor agonists Grant 7,985,748 - McCormick , et al. July 26, 2 | 2011-07-26 |
| Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands App 20110071131 - Bacon; Edward R. ; et al. | 2011-03-24 |
| Functionally selective alpha2C adrenoreceptor agonists Grant 7,803,828 - McCormick , et al. September 28, 2 | 2010-09-28 |
| Functionally Selective Alpha2c Adrenoreceptor Agonists App 20100197562 - De lera Ruiz; Manuel ; et al. | 2010-08-05 |
| Alpha2c Adrenoreceptor Agonists App 20100173823 - McCormick; Kevin D. ; et al. | 2010-07-08 |
| .alpha.2C adrenoreceptor agonists Grant 7,700,592 - McCormick , et al. April 20, 2 | 2010-04-20 |
| Farnesyl protein transferase inhibitors as antitumor agents Grant 7,342,016 - Zhu , et al. March 11, 2 | 2008-03-11 |
| Alpha2C adrenoreceptor agonists App 20080039439 - McCormick; Kevin D. ; et al. | 2008-02-14 |
| Functionally selective alpha2C adrenoreceptor agonists App 20080027100 - McCormick; Kevin D. ; et al. | 2008-01-31 |
| Ambient temperature rapid self-polymerization compositions of high cross-linked or linear type beta-amino-ester alternative co-polymers and their applications App 20070299211 - Chen; Po-Cheng ; et al. | 2007-12-27 |
| Functionally selective alpha2C adrenoreceptor agonists App 20070099872 - McCormick; Kevin D. ; et al. | 2007-05-03 |
| Alpha2C adrenoreceptor agonists App 20070093477 - McCormick; Kevin D. ; et al. | 2007-04-26 |
| Novel farnesyl protein transferase inhibitors as antitumor agents App 20040122018 - Zhu, Hugh Y. ; et al. | 2004-06-24 |
| Novel farnesyl protein transferase inhibitors as antitumor agents App 20030229099 - Zhu, Hugh Y. ; et al. | 2003-12-11 |
| Novel farnesyl protein transferase inhibitors as antitumor agents App 20020198216 - Njoroge, F. George ; et al. | 2002-12-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 